Cargando…
Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study
BACKGROUND: Cancer is a mosaic of tumor cell subpopulations, where only a minority is responsible for disease recurrence and cancer invasiveness. We focused on one of the most aggressive circulating tumor cells (CTCs) which, from the primitive tumor, spreads to the central nervous system (CNS), eval...
Autores principales: | Cordone, Iole, Masi, Serena, Summa, Valentina, Carosi, Mariantonia, Vidiri, Antonello, Fabi, Alessandra, Pasquale, Alessia, Conti, Laura, Rosito, Immacolata, Carapella, Carmine Maria, Villani, Veronica, Pace, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387324/ https://www.ncbi.nlm.nih.gov/pubmed/28399903 http://dx.doi.org/10.1186/s13058-017-0827-4 |
Ejemplares similares
-
Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls
por: Cordone, Iole, et al.
Publicado: (2016) -
The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015) -
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
por: Fabi, Alessandra, et al.
Publicado: (2009) -
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
por: Cerbelli, Bruna, et al.
Publicado: (2022) -
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
por: Maschio, Marta, et al.
Publicado: (2009)